Tuesday, 21 January 2025, 18:04 The European Medicines Company (EMA) has launched an investigation into whether or not weight reduction jabs similar to Ozempic trigger blindness. The Pharmacovigilance Threat Evaluation Committee (PRAC) of the EMA is reviewing medicines containing semaglutide following issues about an elevated danger of creating Naion, a uncommon eye situation, which was instructed by two current research. …
Read More »